Global Enzymes Market Report By Type (Industrial Enzymes and Specialty Enzymes), By Product (Protease, Carbohydrase, Lipase, Polymerase & Nuclease, and Other Product Types), By Source (Plants, Animals, and Microorganisms), By Application (Food and Beverages, Household Care, Bioenergy, Pharmaceutical & Biotechnology, and Other Applications), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Report Overview

The Global Enzymes Market size is expected to be worth around USD 21.3 Billion by 2032 from USD 11.5 Billion in 2022, growing at a CAGR of 6.6% during the forecast period from 2022 to 2032.

The increasing health consciousness of consumers is responsible for the rise in food and beverage demand. It is anticipated to affect product demand during the forecast period positively. Enzymes are extracted from animal components like calf stomachs, microorganisms, and plant materials.

Product manufacturers can now select the necessary host for production by developing cutting-edge technologies, such as transgenic plants or microorganisms. On a commercial level, important businesses frequently employ microorganisms as hosts, such as enzyme-producing yeast, fungi, and bacteria. They are using eco-friendly technologies for a variety of things, like changing the properties of products and making them better.

The global industry will likely expand in the coming years at a significant CAGR. One of the most important drivers of growth is industry-wide technological advancement. The rising demand for bakery and brewing applications is to blame for the high worldwide demand for products. Fruit juices are made with the product to improve fruit yield and quality.

It is also processed to keep the wine’s color, clarity, and organoleptic qualities. The food and beverage industry’s overall growth is primarily influenced by rapid urbanization and the expanding global population, which positively impacts the industry’s expansion. The industry’s expansion is attributed mainly to the worldwide demand for feed for poultry and pigs. The meal helps improve the overall health and well-being of poultry and swine. The global animal feed market is anticipated to boost industry growth during the forecast period.

Key Takeaways

• The global enzyme market is expected to reach a value of USD 21.3 billion by the year 2032.
• The enzyme market is growing at a Compound Annual Growth Rate of 6.6%.
• Enzymes are obtained from sources like microorganisms, calf stomachs, and plant materials.
• Microorganisms, including fungi, enzyme-producing yeast, and bacteria, are commonly used in commercial-level production.
• The industrial segment is expected to have the highest market revenue from 2023 to 2032.
• Carbohydrate-based enzymes are dominating the market due to increased demand in various applications.
• Fungi-based enzymes are driving growth in the microorganisms source segment.
• In 2022, North America held the largest market share with 39.5% of total revenue.
• Asia-Pacific enzyme market had a 23.1% market share.

Type Analysis

The highest market revenue was held by the industrial sector.

The industrial sector held the highest market revenue. Animal feed, food and beverage, detergent, paper and pulp, textile, and wastewater are just a few end-use industries that are seeing an increase in product demand. It is anticipated that product inclusion in detergents will be driven by the expanding use of detergents in industrial and household applications in the emerging economies of China, Brazil, and India.

They are used to convert cellulosic to produce ethanol from cellulosic. The rising rate of fossil fuel depletion is expected to drive up demand for biofuels, which will drive up product demand.

In addition, the paper & pulp processing industry is anticipated to see an increase in product demand as a result of the rising demand for environmentally friendly alternatives and the growing use of paper in the packaging industry as a result of numerous environmental issues.

Due to their widespread use in multiple end-use industries, they can be utilized in biotechnology and research. Because they can carry out chemical reactions in cells, enzymes like catalase, anhydrase, protease, dismutase, elastase, and tyrosinase are utilized in biotechnology. Industry expansion is expected to be further boosted by rising demand for pharmaceuticals in the coming years.

Product Analysis

Due to the increasing demand for various end-use applications, the carbohydrate segment dominates the market.

The carbohydrate segment dominated the industry. This is because there is an increasing demand from various end-use applications, such as pharmaceuticals, animal feed, and food and beverages. During the forecast period, the increasing demand for pectinases and amylases in processing fruit juices for clarification, liquefaction, and maceration to increase product quantity and quality is also anticipated to fuel demand.

The catalytic hydrolysis of protein peptides to amino acids and their breakdown by protease is widely used in numerous applications, such as food, detergents, chemicals, animal feed, and pharmaceuticals.

During the forecast period, it is anticipated that the expanding pharmaceutical, detergent, and chemical end-use industries in emerging economies like India, China, and Brazil will further encourage market expansion. Fats, oils, and triglycerides are all transported, metabolized, and processed by lipases.

It is anticipated that the overall expansion of the industry will be fueled by the rising demand for phospholipase as a biocatalyst from various end-use applications, including oil, biodiesel, agriculture, cosmetics, detergents, bioremediation, food, nutraceuticals, leather, and oil.

Source Analysis

The rising demand for fungi-based enzymes results in the driving of microorganisms’ source segment in the market.

The microorganisms source segment dominated the industry and contributed the highest of global revenue. The rising demand for fungi-based enzymes due to their wide range of end-use applications accounts for a significant portion of the market.

Enzymes derived from fungi are best suited to vegetarian diets, likely increasing product demand in the coming years. The animal source segment had the second-largest global revenue share. Enzymes derived from animals are obtained from the stomach and pancreas of pigs and cattle.

Exocrine pancreatic insufficiency, pancreatitis, and pancreatic cancer are all treated with these products. It is expected to increase its demand in the global pharmaceutical industry over the coming years. Enzymes derived from plants are extracted.

Bromelain is an enzyme that comes from plants and comes from pineapple. Among the essential enzymes found in plants are protease, cellulase, lipase, and amylase. Due to their ability to alleviate acid heartburn, indigestion, and other digestive disorders, the market for plant-based products is expanding rapidly.

Application Analysis

The household care sector has wide application in the global enzymes market; hence, the sector dominates the market.

The household care sector dominated the market with its wide application. As a result of an increase in the use of enzyme-based products as opposed to petrochemical-derived ingredients, which pollute the environment to a greater extent, the trend is anticipated to continue over the forecast period.

The enzyme market forecast for household care has seen significant growth due to the growing public awareness of enzymes’ beneficial effects on the environment. In addition, the desire for enzyme-based products has significantly increased due to the benefits of using enzymes for garment laundering.

The applications of enzymes for enzyme therapy, the synthesis of antimicrobials, the synthesis of APIs, the dynamic kinetic resolution of drugs, and the synthesis of amino acids are reason the pharmaceutical and biotechnology segment of the market is expanding at the fastest rate. Treating diseases like AIDS and cancer has been made possible by incorporating enzymes into drug formulations, opening up opportunities in the sector.

Key Market Segments

Based on Type

• Industrial Enzymes
• Specialty Enzymes

Based on Product Type

• Protease
• Carbohydrase Lipase
• Polymerase & Nuclease
• Others Product Types

Based on Source

• Plants
• Animals
• Microorganisms

Based on Application

• Food and Beverages
• Household Care
• Bioenergy
• Pharmaceutical & Biotechnology
• Other Applications

Drivers

A rising prevalence of chronic ailments results in driving the market growth.

The rising use of enzyme-based products in treating cancer, cardiovascular disease, and lysosomal diseases is expected to drive demand for the products during the forecast period. Pharmaceutical manufacturers are slowly being aware of the integration of biocatalysts into their manufacturing processes.

The high cancer incidence worldwide is one of the main factors driving the market growth during the forecast period. For example, according to the American Cancer Society, 1.8 million new cancers were diagnosed in the United States in 2020, and 606,520 people died of cancer. Therefore, the rising prevalence of such chronic diseases will greatly hold the market’s growth during the forecast period.

Restraints

The lack of standardized regulatory standards and harmonization restraints the growth of the market.

The substrates are transformed into a product by enzymes. Enzymes significantly influence a cell’s life processes. Due to consumers’ growing awareness of their health, the enzyme, a functional food, has seen a significant increase in demand in recent years.

The extensive market is anticipated to expand in the coming years due to the utilization of various technological procedures. Other substances from animals and plants are used in the production of enzymes. Manufacturers are developing diverse strategies to raise product quality.

They are occasionally utilized in numerous industries. They are used in pharmaceutical, textile, and other industries. Enzymes convert complicated food into simpler molecules. The enzyme market will not expand because there are no standard regulatory policies. European regulatory standards related to the approval of additives in feed can pose challenges for product manufacturers in the region. Furthermore, high product prices are one of the key factors restraining the growth of the industry.

Trends

Growing Technological Advancements Offer Enormous Opportunity for Market Growth

Incorporating advanced technology into the manufacturing process is the latest trend in the market. Various companies focus on technological advances to develop innovative products. For example, Codexis, Inc. and Porton Pharma Solutions, Ltd. announced a strategic alliance to add Codexis biocatalytic technology to Porton’s global custom intermediates, and active pharmaceutical ingredients (API) development and manufacturing business has been introduced. This collaboration will accelerate the commercialization and development of novel, low-cost enzyme-based small-molecule drugs.

Opportunities

Wide Industry Scope and Technological Innovations.

To increase the production processes, new technical applications of enzymes are developed. Various companies are implementing enzymes in the textile industry as a substitute for chemicals for producing mild reactions, which leads to chemical-free and clean garments. In the existing enzyme, gene modification has resulted in enormous developments. It enables enzymes to be functional under changing pH levels and temperatures. All the companies have focused on discovering new applications, such as bio-washing and pulp bleaching.

Due to the use of cutting-edge technology in the production of enzymes, substantial growth opportunities are anticipated in the enzyme market. Major market players focus on research and development to offer novel products. The desire for enzymes is expected to expand enormously during the forecast period due to the rise in consumers’ consumption of chronic elements.

The demand for this product is expected to rise due to an increase in the geriatric population and the various diseases they contract. Cancer and cardiovascular diseases benefit greatly from enzymes; The market for enzymes is anticipated to expand in the coming years due to the rising number of cancer patients worldwide. The improved lifestyle and isolation do not increase demand for dietary supplements, which is another factor contributing to the market’s growth.

Regional Analysis

North America held the largest share of the global enzymes market.

In 2022, the industry was dominated by North America, which contributed more than 39.50% of global revenue. It is because major countries in the region have a lot of room for R&D and a variety of end-user manufacturers in the personal care, pharmaceutical, laundry detergent, cosmetics, and food and beverage industries.

Due to rising meat production, particularly in China, the Asia-Pacific region is anticipated to grow at the fastest CAGR between 2022 and 2030. The pharmaceutical and food & beverage industries are driving a significant increase in demand for carbohydrates and protease across the nation.

It is anticipated that the biotechnology industry will expand as applications for polymerase and nuclease enzymes increase. Due to the rising population and income levels in emerging nations like Columbia and Brazil, the textile and food & beverage industries are expected to boost the expansion. The cosmetics and pharmaceutical industries are anticipated to expand in the MEA region due to several factors, including increasing disposable income, rising health awareness, and rising demand for high-end cosmetic products.

Key Regions

• North America
  • The US
  • Canada
  • Mexico

• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe

• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe

• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC

• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America

• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

A Novartis AG Subsidiary, BASF SE and Sandoz GmbH invested in Austria’s Kundl/Schaftenau Campus with the aim to expand BASF SE’s product line and increase production capacity.

Paper and pulp, research, detergents, pharmaceutical, food and beverage, biotechnology, and nutraceuticals, among other end-use applications, are driving the industry’s significant expansion. Key industry players focus on mergers, joint ventures, and acquisitions to grow the business.

For instance, in April 2021, BASF SE and Sandoz GmbH, a Novartis AG subsidiary, invested in Austria’s Kundl/Schaftenau Campus. It aimed to expand BASF SE’s product line and increase production capacity. Some of the key companies involved in the market are Amano Enzyme Inc., Novozymes A/S, Dyadic International, DuPont Nutrition & Biosciences, Aumgene Biosciences, and others.

Market Key Players

• Novozymes
• DSM
• Associated British Foods Plc
• Adisseo
• Advanced Enzyme Technologies
• Enzyme Development Corp.
• Novus International
• DuPont Danisco
• Other Key Players.

Recent Development

• March 2024: Novus International completed the acquisition of BioResource International, Inc. (BRI), a U.S.-based enzyme company. This acquisition brings BRI’s enzyme products and facilities in North Carolina under Novus’s control, enhancing their portfolio and expanding their capacity in the enzyme market. This move is aimed at boosting Novus’s innovation pipeline and strengthening its capabilities in the feed additive space.
• March 2024: Advanced Enzyme Technologies acquired an additional 5.89% stake in JC Biotech, an affiliate specializing in biotechnology. This acquisition raised their total ownership to nearly 96% in JC Biotech, aiming to strengthen their position in the biotech industry.
• January 2024: Novozymes completed a merger with Chr. Hansen, forming a new entity called Novonesis. This merger aims to create a leading global biosolutions partner, enhancing capabilities in diverse markets like food, health, agriculture, and more, focusing on sustainable and innovative biosolutions. This strategic combination is expected to drive significant growth and value creation, with ambitious financial and sustainability targets set for the upcoming years​.
• December 2023: Adisseo opened its new European Research and Innovation Centre, ELISE, in Lyon, France. This center is a strategic addition, aimed at enhancing their research capabilities in process chemistry, engineering, analysis, and nutrition research, which supports their commitment to advanced nutritional solutions and additives for animal feed.

Report Scope